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Abstract
Toxicologists have been increasingly using a class of models to describe a
continuous response in the last few years. This class consists of nested nonlinear
models and is used for estimating various parameters in the models or some mean-
ingful function of the model parameters. Our work here is the first to address
design issues for this popular class of models among toxicologists. Specifically
we construct a variety of optimal designs under model uncertainty and study
their properties for estimating the critical effective dose (CED), which is model
dependent. Two types of optimal designs are proposed: one type maximizes
the minimum of efficiencies for estimating the CED regardless which member in
the class of models is the appropriate model, and (ii) dual-objectives optimal
design that simultaneously selects the most appropriate model and provide the
best estimates for CED at the same time. We compare relative efficiencies of
these optimal designs and other commonly used designs for estimating CED. To
facilitate use of these designs, we have constructed a website that practitioners
can generate tailor-made designs for their settings.
Keyword and phrases: compound optimal design, critical effect size, local
optimal design, maximin optimal design, model discrimination, robust design.
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1 Introduction
This paper addresses design issues for dose response studies in toxicology when the
main outcome is continuous and it is not known a priori which model is an appropriate
one to use. Under this situation, one may consider a class of plausible models within
which we believe lies an adequate model for fitting the data at hand. The issues of
interest are how to design to select the ’best’ model from the class and at the same time
to estimate the critical effective dose (CED) efficiently. The estimated CED is the dose
that toxicologists use to estimate the dose that will result in a user-specified change
in the continuous outcome after accounting for background noise. The user-specified
change in the continuous outcome is usually expressed in terms of the critical effective
size (CES), which is somewhat analogous to specifying ’alpha’ in hypothesis testing in
statistical inference.
Ideally, we want the design to be able to identify the correct model from the postu-
lated class of models and also provide an efficient estimate for the CED, which is a
function of the parameters in the identified model. In this paper, it is further assumed
for simplicity that there is only one independent variable, the dose level. The design
space is the range of dose levels of interest where the researcher selects the dose levels
to observe the outcome. Throughout, we assume all design issues have to be decided
in advance of the study and so sequential designs are not considered.
By design, the researcher has to select the number of dose levels from the design space
to observe the continuous outcome, decide where these dose levels are and the number
of replicates at each of these dose levels. Here the design space is the range of dose
levels that the researcher wants to include in the study. We further generalize the de-
sign problem to one for finding continuous designs, meaning that we now view designs
as probability measures on the design space. Continuous designs were proposed by
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Kiefer in the late 1950s and have been shown to be much more amendable to analyti-
cal description and study than exact design. In our setup, we assume the total number
of observations N for the whole study is pre-determined by cost or time and contin-
uous designs are implemented by naturally rounding the possibly non-integer number
of observations required at each dose to an integer number, subject to the number of
observations at each dose sum to N .
Here is a simple illustration of a continuous design on the design space [0, 25]. Let
ξ be a continuous design that takes half the observations at dose level 5 and half at
dose level 20. We denote this design by writing ξ = {5, 20; 1/2, 1/2}; the first part
denotes the two dose levels and the latter part denotes the corresponding proportion
of observations to be taken at each of the dose levels. In the terminology of optimal
design literature, the dose levels of the design ξ are called support points and the corre-
sponding proportions are called weights. If N = 20, this implies the continuous design
ξ takes 10 observations at dose level 5 and 10 observations at dose level 20. If N = 25,
the same continuous design ξ can either take 12 observations at dose level 5 and 13
observations at dose level 20, or alternatively, 13 observations at dose level 5 and 12
observations at dose level 20. An optimal (continuous) design is one that maximizes or
minimizes a given optimality criterion over all designs on the design space. Further de-
tails and motivations for working with continuous designs are given in the voluminous
collection of papers by Kiefer and edited by Brown, et al. (1985). Optimal rounding
procedures to convert a continuous design to an exact design for implementation are
given in Rieder and Pukelsheim (1992).
Addressing design issues invariably requires model assumptions that specify how the
mean outcome relates to the independent variable. Usually a specific functional form
is assumed either from experts’ opinions or from the science of the problem, see Gaylor
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and Chen (1993), Catalano et al. (1993), Slob and Pieters (1998), Oscar (2004),
Moerbeek, Piersma and Slob (2004), among many others. When it is problematic
to specify a single model to describe the functional relationship between the mean
outcome and the dose level, a common strategy is to work with a class of plausible
nested models assumed to include the ’true’ model. This class of models is usually
arrived at after consultation with experts in the area. As an illustration, consider a
simple class of nested models widely used in the study of enzyme kinetics. The class
consists of just two models: the well known Michaelis-Menten and the Emax-model.
The former is frequently employed in biochemistry and is described by
E(Y ) =
ax
b+ x
.
Here Y is the velocity of the enzyme kinetics and x is the concentration of the substract.
The two parameters are a and b with the latter often referred to as the Michaelis-Menten
constant. A more flexible model to study enzyme kinetics is the Emax model defined
by
E(Y ) =
axh
b+ xh
.
The extra parameter h in the Emax-model permits the shape of the response curve
to be skewed and takes on different steepness as the concentration of the substract is
varied. The challenges here from the design perspective are that we do not know at
the onset which one of these two models is a more suitable model to use and it is well
known that an optimal design can be very sensitive to model assumptions. If one con-
siders the Michaelis-Menten alone, the optimal design for estimating the parameters a
and b in this model does not allow one to estimate the parameter h in the Emax model
and, if one assumes the Emax model holds, the optimal design for estimating all the
three parameters h, a and b may be inefficient for only estimating a and b should the
Michaelis-Menten model prove to be a more appropriate model. Such design problems
are important and arise frequently in practice across disciplines. To our knowledge,
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only a couple of papers have tried to address such design questions seriously. A main
reason for lack of research in this area is that there are serious technical difficulties
involved, especially for nonlinear models.
A general strategy to address such design issues is to work with experts in the area and
first identify a class of plausible modes that will most likely include the true model.
The plausible models within this class should be nested allowing one to be built upon
another; typically this means the ’largest’ model has the largest number of parameters
and the next ’largest’ model is obtained from the ’largest’ one by specifying one or
more parameters equal to some user-selected fixed values. In our above illustration,
our class of plausible models consists of the Emax and Michaelis-Menten models and
it is clear that when h = 1, the Emax-model reduces to the Michaelis-Menten model.
Once this class is identified, one works assuming the largest model holds. In our illus-
tration, one seeks an efficient design to estimate h in the Emax model as accurately as
possible and at the same time also have efficient estimates for the parameters a and
b when the Michaelis-Menten model holds. Dette, Melas and Wong (2005) addressed
this particular design problem and provided details.
The motivation for this work comes from repeated proposals recently in the toxicology
literature to use a class of models to study a continuous outcome in toxicological studies
[Moerbeek, Piersma and Slob (2004), Piersma et al. (2002), Woutersen et al. (2001),
Slob (2002)]. In all these papers, the interest was only in estimation problems and so
they did not consider design issues. As is typical in such publications, the rationale for
the design employed in the study is not explained. Here are a few examples of designs
used in toxicological studies and their outcomes. In Piersma et al. (2002), rats were
prenatally exposed to diethylstilbestrol and the design had 16 animals in each of the
10 dose groups at 0, 1.0, 1.7, 2.8, 4.7, 7.8, 13, 22, 36 and 60 mg/kg body weight per
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day. In Woutersen et al. (2001), rats were exposed to Rhodorsil Silane in a 28-day
toxicity study and 3 designs were employed: the first one had 10 rats in each of the
7 dose groups (7x10 design) and the second had 5 rats in each of the 7 dose groups;
the 7 dose groups were 0, 50, 150, 300, 450, 600 and 750 mg/kg body weight/day. The
third had 10 rats in each of the 4 dose groups at 0, 50, 150 and 450 mg Rhodorsil
Silane/kg body weight/day. There were many continuous outcomes in each of these
studies. In Piersma et al. (2002), they included maternal body weight on gestation
day 21, maternal serum estradiol concentration at gestation day 21, weights of fetuses
at gestation day 21, immunological responses such as IgG and IgM to sheep red blood
cell challenge and pup weights at days 1 and 21. In Woutersen et al. (2001), their main
goals were to estimate various critical effective doses; these are doses that will result in
a user-specified level of toxicity found in rats over the background noise. Outcomes of
main interest were responses in haematology and clinical chemistry. In the discussion
section, we comment on the performance of these designs.
In this paper, we develop optimal designs for identifying an appropriate model within
the class of models and also at the same time provide reliable estimate for the critical
effect dose (CED) using the selected model. The CED is a popular measure among
toxicologists to estimate the dose level that will result in a user-specified anticipated
change in the continuous outcome beyond the background noise. Design issues are al-
ways difficult to address and we begin first by considering local optimal designs because
they are the easiest to construct for nonlinear models (Chernoff, 1953). These designs
require the user to supply nominal values of the model parameters before the optimal
design can be constructed. Nominal values represent the best guess for the true values
of the set of parameters and are usually obtained either from prior similar experiments
or experts’ opinion. When model assumptions are mis-specified, it is well known that
the resulting local optimal design can lose substantial efficiency. To overcome this
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risk, we propose maximin optimal designs that have been shown to be robust to mis-
specification of model assumptions in other settings , see for example, Biedermann,
Dette and Pepelyshev (2006) and Dette et al. (2008). These maximin optimal design
maximizes the minimum efficiency regardless which model in the class of models is the
appropriate model. As such, these optimal designs provide some protection against
picking a wrong model from the postulated class. In addition, we construct compound
optimal design to account for the dual objectives of discriminating models and at the
same time want the design to deliver a user-specified level of efficiency for estimating
the CED.
In section 2, we describe the class of nonlinear models and the design criterion for
estimating CED. We describe relationships among models in the class and provide
local optimal design for estimating the CED for each member in the class. We also
show how an optimal design constructed for a specific setup can be used to deduce the
optimal design under another setup where assumptions on the design space and model
parameters are different. In section 3, we construct maximin optimal designs and com-
pound optimal designs for toxicology studies and assess their robustness properties to
model mis-specification and their effectiveness for discriminating between models and
estimating CED at the same time. We also compare performance of selected uniform
designs that are intuitively appealing to practitioners. These designs take equal num-
ber of observations over a set of equally spaced dose levels. In section 4, we discuss
four practical issues. First, we construct and compare corresponding optimal designs
for log-normally distributed outcomes, which is another popular assumption used by
toxicologists. Secondly, we investigate efficiencies of several designs used by toxicol-
ogists. Thirdly, we perform a simulation study to assess how our optimal designs
perform in a real example with a relatively small sample size. Finally, we introduce
the reader to our design web site that the reader can use freely to generate a variety
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of optimal designs for a broad range of models frequently used in the biological sciences.
2 Model Uncertainty and CED-Optimality
Moerbeek, Piersma and Slob (2004), Woutersen et al. (2001), Piersma, et al. (2002)
and Slob (2002) proposed and used the following class of models in several toxicological
studies. The authors showed with justifications that the class of models is sufficiently
flexible to accommodate typical continuous outcomes of interest in toxicological studies.
For each of these models defined on the given design space [0, T ], Y is the response
and t is the dose level; all parameters in the mean response are components of the
px1-vector parameter θ .
(2.3) E(Y ) = ae−bt with a > 0, b > 0,
(2.4) E(Y ) = ae−bt
d
with a > 0, b > 0, d ≥ 1,
(2.5) E(Y ) = a(c− (c− 1)e−bt) with a > 0, b > 0, c ≥ 0,
(2.6) E(Y ) = a(c− (c− 1)e−btd) with a > 0, b > 0, c ≥ 0, d ≥ 1.
This class consists of models nested within one another, where ’smaller’ models can
be obtained from the ’largest’ model by setting specific parameters in the ’largest’
model equal to specific values. For each t ∈ [0, T ], an observation Y is recorded and
all observations are assumed to be independent normally distributed with the same
variance, say σ2 > 0, and the expectation of Y observed at t is given by
E[Y ] = η(t, θ)
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where η(t, θ) is one of the functions (2.3)-(2.6). In what is to follow, we suppress the
p-dimensional parameter θ in η(t, θ) for simplicity when there is no confusion, and
similarly for other notation such as f(t, θ) and g(θ) defined below.
In toxicological studies with a continuous outcome, the benchmark response is usually
expressed in terms of a critical effect size (CES). This is the amount that we expect
the percent change in the average level of the outcome compared with the background
noise. In practice, CES is user-specified and traditionally set equal to 0.05 or 0.10. For
a given mean response η(t) and a user-selected CES, the critical effective dose CED is
calculated from
CES = −η(CED)− η(0)
η(0)
if η(t) is a decreasing function. All our functions η(t) defined in (2.3)-(2.6) are decreas-
ing.
The parameters in the above models may or may not all have meaningful interpre-
tations, but frequently a re-parametrization of the mean function or working with a
function of the model parameters has a practical meaning. By inverting the above
functions, such as the mean function in (2.6), it is straightforward to show that
CED = CED(b, d, c) =
(
− ln
c−1+CES
c−1
b
) 1
d
.
The corresponding expressions for CED for other models can be directly deduced by
setting c = 0 for models (2.3) and (2.4) and by setting d = 1 for models (2.3) and (2.5).
Thus the CED is the dose that results in a percent change in the mean response relative
to the background noise and the magnitude of the anticipated change is specified by
the critical effect size (CES).
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To estimate the confidence interval for CED for a specific model using design ξ, one
uses the delta method to obtain its asymptotic variance and then find a design to
minimize it. Specifically, we have
Var(ĈED) ≈ σ
2
N
Φ(ξ)
where
Φ(ξ) = gT (θ)M−(ξ, θ)g(θ), and g(θ) =
∂ CED
∂θ
.
For the vector of the parameters θ = (a, b, d, c)T the local CED-optimal design
minimizes the function Φ(ξ) by choice of the design ξ. The matrixM(ξ, θ) in the above
expressions is the information matrix for the specific model η(t) using an arbitrary
design ξ and M−(ξ, θ) is a generalized inverse of M(ξ, θ). We call a design nonsingular
if its information is nonsingular; otherwise it is a singular design. For a specific model
η, let f(t, θ) = ∂η(t,θ)
∂θ
and recall that the information matrix is given by
M(ξ, θ) =
∫ T
0
f (t, θ)fT (t, θ)dξ(t).
The corresponding regression vectors f(t, θ) for different models are
f (2.3)(t, θ) = f(t, a, b) = (e−bx,−ate−bt)T ,
f (2.4)(t, θ) = f(t, a, b, d) = (e−bt
d
,−atde−btd ,−abtd ln(t)e−btd)T ,
f (2.5)(t, θ) = f(t, a, b, c) = (c− (c− 1)e−tb, a(c− 1)te−tb, a(1− e−tb))T ,
f (2.6)(t, θ) = (c− (c− 1)e−btd , a(c− 1)tde−btd , a(c− 1)td ln(t)be−btd , a(1− e−btd))T .
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and the corresponding vectors g(θ) are
g(2.3)(θ) = g(a, b) =
(
0,
ln(1− CES)
b2
)T
g(2.4)(θ) =
(
0,− 1
db
(
− ln(1− CES)
b
) 1
d
,− 1
d2
(
− ln(1− CES)
b
) 1
d
ln
(
− ln(1− CES)
b
))T
g(2.5)(θ) =
(
0,
ln c−1+CES
c−1
b2
,
1− c−1+CES
c−1
b(c− 1 + CES)
)T
,
g(2.6)(θ) =
0,− 1
db
(
− ln
c−1+CES
c−1
b
) 1
d
,− 1
d2
(
− ln
c−1+CES
c−1
b
) 1
d
ln
(
− ln
c−1+CES
c−1
b
)
,
(
− ln
c−1+CES
c−1
b
) 1
d 1− c−1+CES
c−1
d(c− 1 + CES) ln c−1+CES
c−1
T .
The next five technical results provide analytical descriptions and properties of lo-
cal CED-optimal design for each model. The first one shows that local CED-optimal
design does not depend on the value of the parameter a, and the next four results
describe the structure of the local CED-optimal designs for the four nonlinear models
(2.3)-(2.6). We provide an illustrative proof of our results for model (2.3) only; the
arguments for the other models are similar. For our class of models, the results also
show how optimal design for a particular design setting can be deduced from another
design setting by only considering values of b and T. Our technical justifications use a
celebrated geometric result called Elfving’s theorem which is widely discussed in design
monographs, such as in Pa´zman (1986, p.71) or Pukelsheim (1993, p.50). We provide
only proofs for Lemma 2.1 and 2.2; the rest are similar.
Lemma 2.1 A local CED-optimal design does not depend on a.
Proof. The statement follows from the fact that an optimality function have a form
Φ(ξ, θ) = a2−2pΦ(ξ, θ˜)
where (a, θ˜T ) = θT ∈ Rp and p is the number of parameters.
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Lemma 2.2 Let u∗ ≈ 1.278 be a unique solution of equation e−u = u− 1. For model
(2.3) a local CED-optimal design does not depend on a and CES and is given by{
0, u∗/b;
e−u
∗
1 + e−u∗
,
1
1 + e−u∗
}
if T > u∗/b ; otherwise it is given by{
0, T ;
e−bT
1 + e−bT
,
1
1 + e−bT
}
.
Proof. By Elfving’s theorem, there exists a representation
vg = w∗1f(t
∗
1)− w∗2f(t∗2)(2.7)
for some v ∈ R and gTM−(ξ∗)g = 1/v2. Moreover, points of optimal design lie on the
boundary of Elfving set. Thus, t∗1 = 0. For large enough values of T , the point f(t2)
belongs to the boundary if t2 is small; otherwise it does not. The crucial value of t2 is
a solution of the equation
f ′2(t2)
f ′1(t2)
=
f2(t2) + f2(0)
f1(t2) + f1(0)
.
Straightforward calculation shows that t∗2 = u
∗/b. From the equation for the first
coordinate of (2.7), we determine directly the weights w∗1 and w
∗
2 for the optimal
design.
Lemma 2.3 For model (2.4), the local CED-optimal design has one of three possible
forms. It is either given by 2-point singular design{
0, CED;
1− CES
2− CES ,
1
2− CES
}
if the parameter b is small enough, or it has the form
{0, t∗2, t∗3;w∗1, w∗2, w∗3}
if t∗3 < T ; otherwise it takes the form
{0, t∗2, T ;w∗1, w∗2, w∗3}.
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Moreover, for 3-point optimal designs, we have
t∗i (b, d, T ) = Tt
∗
i (bT
d, d, 1), w∗i (b, d, T ) = w
∗
i (bT
d, d, 1).
t∗i (b, 1, 1) = (t
∗
i (b, d, 1))
d , w∗i (b, 1, 1) = w
∗
i (b, d, 1).
For a 3-point optimal design, Elfving theorem implies that the weights of the optimal
design are solutions of the equation
(g
...f(t∗3)− f(0)
...f(t∗3) + f(t2))(v, w1, w2)
T = f(t∗3)
with t2 = t
∗
2 and 2nd point t
∗
2 is a solution of ∂v/∂t2 = 0 where
v = v(t2) =
det(f(t∗3)
...f(t∗3)− f(0)
...f(t∗3) + f(t2))
det(g
...f(t∗3)− f(0)
...f(t∗3) + f(t2))
.
There is no explicit solution for model (2.4) but is an explicit solution for model (2.5).
Lemma 2.4 For model (2.5), the local CED-optimal design has one of two forms. It
is either given by 2-point singular design{
0, CED;
1− CES
2− CES ,
1
2− CES
}
if the parameter b is small enough or c is large enough; otherwise, it has the following
form
{0, t∗2, T ;w∗1, w∗2, w∗3},
where
t∗2 = t
∗
2(b, c, T ) =
1− (1 + bT )e−bT
b(1− e−bT ) .
Moreover, for 3-point optimal designs, we have
t∗i (b, c, T ) = Tt
∗
i (bT, c, 1), w
∗
i (b, c, T ) = w
∗
i (bT, c, 1),
points t∗i (b, c, T ) do not depend on c.
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Lemma 2.5 For model (2.6), the local CED-optimal design has one of two form. It
is either a singular 2-point design given by{
0, CED;
1− CES
2− CES ,
1
2− CES
}
if the parameter b is small enough or c is large enough; otherwise it has the form
{0, t∗2, t∗3, T ;w∗1, w∗2, w∗3, w∗4}.
Moreover, for 4-point optimal designs, we have
t∗i (b, d, c, T ) = Tt
∗
i (bT
d, d, c, 1), w∗i (b, d, c, T ) = w
∗
i (bT
d, d, c, 1),
t∗i (b, 1, c, 1) = (t
∗
i (b, d, c, 1))
d , w∗i (b, 1, c, 1) = w
∗
i (b, d, c, 1)
and points t∗i (b, d, c, T ) do not depend on c.
Tables 1 and 2 show local CED-optimal designs for each of the four models when
CES = 0.05 and selected values for b and T . As is described in the above results, the
local CED-optimal design may be a singular 2-point design for models (2.4)-(2.6) or a
saturated design where the number of points equal to the number of model parameters.
3 Maximin CED-optimal Design and Compound
Optimal Design
The local optimal design for estimating CED depends on the assumed model and the
nominal values of the model parameters. When the nominal values are mis-specified,
local optimal designs can lose substantial efficiency. This problem is further com-
pounded when there is model uncertainty. This implies that local optimal designs
while potentially useful as a starting point, are unlikely to be adequate for practical
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Table 1: Local CED-optimal designs for model (2.3) and for model (2.6) with d = 1,
c = 0 on the design space [0, T ] for various values of the parameter b and CES = 0.05.
model (2.3) model (2.6)
T b t1 t2 w1 w2 t1 t2 t3 t4 w1 w2 w3 w4
1 0.1 0 1 0.475 0.525 0 0.513 0.487 0.513
1 0.5 0 1 0.377 0.623 0 0.103 0.487 0.513
1 1.0 0 1 0.269 0.731 0 0.113 0.596 1 0.388 0.479 0.097 0.036
5 0.1 0 5 0.377 0.623 0 0.513 0.487 0.513
5 0.5 0 2.557 0.218 0.782 0 0.430 2.482 5 0.337 0.463 0.141 0.058
5 1.0 0 1.278 0.218 0.782 0 0.277 1.718 5 0.316 0.454 0.159 0.071
Table 2: Local CED-optimal designs for model (2.4) with d = 1 and for model (2.5) with
c = 0 on the design space [0, T ] for various values of the parameter b and CES = 0.05.
model (2.4) model (2.5)
T b t1 t2 t3 w1 w2 w3 t1 t2 t3 w1 w2 w3
1 0.1 0 0.513 0.487 0.513 0 0.513 0.487 0.513
1 0.5 0 0.305 1 0.378 0.515 0.106 0 0.459 1 0.353 0.532 0.115
1 1.0 0 0.251 1 0.344 0.511 0.145 0 0.418 1 0.317 0.554 0.129
5 0.1 0 1.523 5 0.378 0.515 0.106 0 2.293 5 0.353 0.532 0.115
5 0.5 0 0.672 4.507 0.305 0.462 0.233 0 1.553 5 0.261 0.593 0.146
5 1.0 0 0.336 2.253 0.305 0.462 0.233 0 0.966 5 0.232 0.613 0.155
implementation. However, local optimal designs are useful as a first step to construct-
ing more versatile and robust designs to model assumptions. We now discuss two
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design strategies that utilize local optimal designs.
The maximin approach of designing a study provides an alternative that can be ap-
pealing [see Dette (1995), Mu¨ller (1995) and Mu¨ller and Pa´zman (1998) among others].
Procedurally, one first considers the efficiency of a design for estimating the CED rela-
tive to each of the models; among these relative efficiencies, the maximin CED-optimal
design is the one that maximizes the minimum of these relative efficiencies. Technically,
for a fixed θ we call the design that maximizes
min{eff(2.3)CED(ξ, θ), eff(2.4)CED(ξ, θ), eff(2.5)CED(ξ, θ), eff(2.6)CED(ξ, θ)}
over all designs on the design space a maximin CED-optimal design, where CED-
efficiency (for each model) is given by
effCED(ξ) =
minξ˜ Φ(ξ˜)
Φ(ξ)
.
The last ratio is obviously a number between 0 and 1 and represents the reduction in
sample size from use of the optimal design compared with using the design ξ for the
same level of precision for estimating CED. For example if effCED(ξ) = 0.5, the design
ξ needs to be replicated twice to obtain an CED estimate as accurate as the estimate
from the local optimal design for estimating CED. As expected, maximin optimal de-
signs are difficult to find and defy analytical description. In particular, no closed form
formulae are available. They have to be found numerically and several maximin opti-
mal designs are shown in Table 3 for selected values of b and T with their efficiencies
relative to the local CED-optimal designs for models (2.3)-(2.6).
In practice, maximin CED-optimal designs are found by first maximizing the optimality
criterion within the class of all 4-point designs on the given design space. This is because
4 points are required for CED estimation in all models (2.3)-(2.6). The optimization is
performed with the NelderMead algorithm in the matlab package. After the optimal
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4-point design is found, we next search for the optimal design within the class of all 5
points designs, and repeat the procedure, each time increase the number of points by
unity, until no reduction in the criterion value is observed.
Table 3: Maximin CED-optimal designs for models (2.3)-(2.6) on the design space
[0, T ] for various values of the parameter b with d = 1, c = 0 and CES = 0.05 and their
efficiencies.
T b t1 t2 t3 t4 w1 w2 w3 w4 eff
(2.3)
CED eff
(2.4)
CED eff
(2.5)
CED eff
(2.6)
CED
1 0.1 0 0.513 1 0.417 0.296 0.287 0.686 0.686 0.686 0.692
1 0.5 0 0.183 0.612 1 0.299 0.228 0.231 0.242 0.597 0.636 0.597 0.597
1 1.0 0 0.170 0.594 1 0.261 0.217 0.288 0.234 0.615 0.615 0.615 0.615
5 0.1 0 0.914 3.059 5 0.299 0.228 0.231 0.242 0.597 0.636 0.597 0.597
5 0.5 0 0.820 2.451 5 0.237 0.292 0.350 0.121 0.655 0.655 0.655 0.655
5 1.0 0 0.529 1.545 5 0.236 0.366 0.326 0.072 0.639 0.639 0.639 0.673
3.1 Multiple-objective Optimal Designs
In practice, designs have several objectives in mind. There are interests in estimating
various parameters in the model and frequently not all are of equal interest. For in-
stance in the Michaelis-Menten model, the Michaelis-Menten constant b is clearly of
much greater interest than the constant a. This means that the design should pro-
vide much more accurate estimate for the parameter b (the primary objective) than
the parameter a (secondary objective). In this case, one may require that the design
deliver at least 90% efficiency for estimating b and subject to this constraint devote
the rest of the resources to estimating a. This is an example of a constrained optimal
design discussed seminally in Stigler (1971), Studden (1982) and Lee (1988), where
18
they considered homoscedastic polynomial models. Such optimal designs are easy to
motivate and interpret but usually they are difficult to find. When the objectives can
be expressed as convex functionals of the information matrix, Cook and Wong (1994)
proposed finding dual-objective optimal designs indirectly by first finding compound
optimal designs.
Given two convex optimality criteria, it is tempting to consider a convex combination
of the two criteria, which is also convex. This implies that for each λ between 0 and
1, one can straightforwardly find the compound optimal design ξλ that minimizes the
convex combination. We next construct the efficiency plot that graphs the two ef-
ficiencies of ξλ versus values of λ between 0 and 1. Cook and Wong (1994) showed
that the efficiency of ξλ under the primary criterion is always monotonically increasing
and the efficiency under the secondary criterion is always monotonically decreasing.
This is not surprising because resources have to be compromised for attaining the dual
objectives. The slopes in the plots show how competitive the two objectives are, with
steep slopes representing that much of one type of efficiency has to be given up in ex-
change for attaining more of the other efficiency. To relate compound optimal designs
to constrained optimal designs, one uses the efficiency plots to arrive at a meaningful
choice of λ. Specifically, the desired constrained optimal design is found by first draw-
ing a horizontal line across the plot at the desired efficiency level sought for under the
primary criterion, say 90% as in the above illustration. We then note the value of λ,
say λ∗, that corresponds to the point where this horizontal line meets the (increasing)
efficiency plot for the primary criterion and conclude that ξλ∗ is the sought constrained
optimal design. Details and theoretical explanation, along with worked out examples
and illustrative efficiency plots are given in Cook and Wong (1994), Zhu, Zeng and
Wong (2000), and Zhu and Wong (2000). See also Imhof and Wong (2000) where effi-
ciency plots were used to find maximin optimal design in nonlinear models.
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The advantage of the setup just described is that the researcher is in full control; he or
she decides which is the primary criterion and sets the efficiency level required under
the first criterion. This represents the level he or she is willing to compromise on the
two objectives. Clearly, this method also works when all criteria are concave instead
of convex, in which case we seek to maximize rather than minimize each criterion.
The procedure just outlined can also be extended to find multiple-objective optimal
designs; in our problem at hand, we set design criteria for discriminating between each
pair of models and for CED estimation. Specifically, for a fixed θ we call the design
that maximizes
min{eff(2.3)CED(ξ, θ), eff(2.4)CED(ξ, θ), eff(2.5)CED(ξ, θ), eff(2.6)CED(ξ, θ),
eff(2.4)−(2.3)(ξ, θ), eff(2.5)−(2.3)(ξ, θ), eff(2.6)−(2.5)(ξ, θ), eff(2.6)−(2.4)(ξ, θ)}
over all designs on the design space a maximin compound design where eff(M1)−(M2)(ξ, θ)
is an efficiency of design ξ for discrimination two models M1 and M2. Such designs are
efficient for CED estimation and discrimination. Selected maximin optimal designs are
shown in Table 4 and their efficiencies for estimating CED under each model and for
discriminating between pairs of models are shown in Table 5.
Our proposed maximin compound designs still depend on nominal values of the pa-
rameters. One could incorporate this uncertainty of the nominal values in a compound
optimality criterion. We refer the reader to Biedermann, Dette and Pepelyshev (2006),
Dette et al. (2008) for details but note that our small scale investigation showed that
maximin optimal designs are not sensitive to small changes in the nominal values of
the parameters in the models considered here.
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Table 4: Maximin compound designs for models (2.3)-(2.6) on the design space [0, T ]
for various values of the parameter b with d = 1, c = 0 and CES = 0.05.
T b t1 t2 t3 t4 w1 w2 w3 w4
1 0.1 0 0.173 0.622 1 0.361 0.152 0.281 0.205
1 0.5 0 0.183 0.612 1 0.299 0.228 0.231 0.242
1 1.0 0 0.170 0.594 1 0.261 0.217 0.288 0.234
5 0.1 0 0.914 3.059 5 0.299 0.228 0.231 0.242
5 0.5 0 0.698 2.398 5 0.186 0.225 0.298 0.291
5 1.0 0 0.639 1.899 5 0.147 0.267 0.240 0.347
Table 5: CED-Efficiencies and efficiencies of discrimination of maximin compound
designs for models (2.3)-(2.6) on the design space [0, T ] for various values of the pa-
rameter b with d = 1, c = 0 and CES = 0.05.
CED efficiency efficiency of discrimination
T b (2.3) (2.4) (2.5) (2.6) (2.4)-(2.3) (2.5)-(2.3) (2.6)-(2.5) (2.6)-(2.4)
maximin compound design
1 0.1 0.610 0.620 0.620 0.610 0.622 0.651 0.610 0.694
1 0.5 0.597 0.637 0.597 0.597 0.678 0.634 0.720 0.737
1 1.0 0.615 0.615 0.615 0.615 0.643 0.626 0.743 0.803
5 0.1 0.597 0.637 0.597 0.597 0.677 0.634 0.720 0.737
5 0.5 0.605 0.633 0.605 0.605 0.697 0.605 0.716 0.813
5 1.0 0.456 0.456 0.596 0.474 0.456 0.456 0.527 0.517
4 Discussion
This closing section has four purposes aimed at the practitioners. The first purpose
is to address distributional assumption on the error terms; in particular we construct
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optimal designs under the assumption of log-normality and compare results obtained
under the normality assumption. Secondly, we discuss efficiencies of designs used by
toxicologists relative to our proposed optimal designs. The third purpose is to evaluate
how well our maximin optimal designs perform in practice using a small simulation
study. The final purpose is to draw attention to our design web site where many types
of optimal designs for several models can be generated under user-specified settings.
4.1 Distributional assumptions
Sometimes toxicologists prefer to assume the continuous outcomes are log-normally
distributed, see for example, Slob (2002). The dose-response model is fitted on the
log-scale, where both the model and the data are log-transformed. After fitting the
model, the model and the data may be back-transformed to the original scale for pur-
poses of plotting and interpretation. We now show how our method can be extended
to accommodate the log-normality assumption to find optimal designs.
It suffices to note here that we now assume logarithm of different observations are
independent with the same variance, say σ2 > 0, and have expectation
E[lnY ] = ln η(t, θ)
where η(t, θ) is one of the 4 functions listed at the beginning of Section 2. Proceeding
as in Section 2, one obtains an expression for the CED and the asymptotic variance of
the estimated CED. The key difference is that the information matrix is now given by
M˜(ξ, θ) =
∫ T
0
f˜ (t, θ)f˜T (t, θ)dξ(t)
where f˜(t, θ) = 1
η(t,θ)
∂η(t,θ)
∂θ
.
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It follows that the vector f˜(t, θ) for each model is now different from the one under
normality assumption in Section 2. However, the vector g(θ) for each model remains
the same whether we assume the errors are normally or log-normally distributed. The
next few tables display selected maximin CED-optimal designs (Table 6), maximin
compound optimal designs (Table 8) under log-normal assumption and their efficien-
cies. From Tables 3 and 6, we observe that the maximin optimal designs obtained
under the normality and log-normality assumptions do not appear to be substantially
different. The same is observed for maximin compound designs in Tables 4 and 7.
Table 6: Maximin CED-optimal designs for models (2.3)-(2.6) with lognormality as-
sumption on the design space [0, T ] for various values of the parameter b with d = 1,
c = 0 and CES = 0.05 and their efficiencies.
T b t1 t2 t3 t4 w1 w2 w3 w4 eff
(2.3)
CED eff
(2.4)
CED eff
(2.5)
CED eff
(2.6)
CED
1 0.1 0 0.513 1 0.430 0.289 0.281 0.691 0.691 0.691 0.691
1 0.5 0 0.196 0.638 1 0.334 0.224 0.221 0.221 0.620 0.655 0.620 0.620
1 1.0 0 0.195 0.655 1 0.326 0.202 0.240 0.232 0.636 0.636 0.636 0.636
5 0.1 0 0.982 3.191 5 0.334 0.224 0.221 0.221 0.620 0.655 0.620 0.620
5 0.5 0 1.188 3.485 5 0.334 0.198 0.238 0.231 0.643 0.643 0.643 0.643
5 1.0 0 1.450 3.758 5 0.347 0.204 0.239 0.211 0.644 0.644 0.644 0.644
4.2 Efficiency of commonly used designs
Now we discuss efficiencies of designs described in Section 1 relative to our proposed
optimal designs. Recall that these are some of the types of designs commonly used
by toxicologists in practice. Specifically, designs and nominal values of parameters are
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Table 7: Maximin compound designs for models (2.3)-(2.6) with lognormality assump-
tion on the design space [0, T ] for various values of the parameter b with d = 1, c = 0
and CES = 0.05.
T b t1 t2 t3 t4 w1 w2 w3 w4
1 0.1 0 0.176 0.628 1 0.374 0.155 0.271 0.200
1 0.5 0 0.196 0.638 1 0.334 0.224 0.221 0.221
1 1.0 0 0.199 0.659 1 0.325 0.202 0.242 0.232
5 0.1 0 0.981 3.191 5 0.334 0.224 0.221 0.221
5 0.5 0 1.174 3.469 5 0.322 0.199 0.241 0.238
5 1.0 0 1.357 3.683 5 0.312 0.206 0.250 0.233
Table 8: CED-Efficiencies and efficiencies of discrimination for compound optimal
designs for models (2.3)-(2.6) on the design space [0, T ] with lognormality assumption
and various values of the parameter b with d = 1, c = 0 and CES = 0.05.
CED efficiency efficiency of discrimination
T b (2.3) (2.4) (2.5) (2.6) (2.4)-(2.3) (2.5)-(2.3) (2.6)-(2.5) (2.6)-(2.4)
maximin compound design
1 0.1 0.614 0.622 0.627 0.614 0.628 0.648 0.614 0.688
1 0.5 0.620 0.655 0.620 0.620 0.675 0.628 0.721 0.727
1 1.0 0.636 0.636 0.636 0.636 0.645 0.636 0.707 0.753
5 0.1 0.620 0.655 0.620 0.620 0.675 0.628 0.722 0.727
5 0.5 0.643 0.643 0.643 0.643 0.649 0.643 0.678 0.730
5 1.0 0.640 0.640 0.640 0.640 0.644 0.640 0.662 0.729
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Table 9: CED-Efficiencies and efficiencies of discrimination for designs used by toxi-
cologists for models (2.3)-(2.6) with lognormality assumption on the design space [0, T ]
for various values of the parameter b, d and c and CES = 0.05 whereM∗ is the minimal
efficiency of maximin compound design.
CED efficiency efficiency of discrimination
b c d M∗ (2.3) (2.4) (2.5) (2.6) (2.4)-(2.3) (2.5)-(2.3) (2.6)-(2.5) (2.6)-(2.4)
design 0, 0.5, 1.5, 3, 4.5, 6, 7.5 (in 100mg/kg scale), T = 7.5
0.04 1 0 0.597 0.492 0.504 0.563 0.361 0.558 0.579 0.594 0.666
0.06 1 0 0.616 0.492 0.517 0.570 0.419 0.558 0.579 0.594 0.666
0.09 1 0 0.628 0.492 0.526 0.574 0.464 0.558 0.579 0.594 0.665
design 0, 0.5, 1.5, 4.5 (in 100mg/kg scale), T = 7.5
0.04 1 0 0.597 0.217 0.375 0.185 0.551 0.245 0.057 0.126 0.032
0.06 1 0 0.616 0.217 0.348 0.165 0.497 0.245 0.053 0.121 0.028
0.09 1 0 0.628 0.217 0.331 0.150 0.375 0.245 0.047 0.114 0.024
design 0, 0.5, 1.5, 4.5 (in 100mg/kg scale), T = 4.5
0.04 1 0 0.607 0.602 0.526 0.398 0.548 0.681 0.498 0.370 0.294
0.06 1 0 0.596 0.602 0.566 0.406 0.517 0.681 0.493 0.364 0.286
0.09 1 0 0.612 0.602 0.590 0.406 0.490 0.681 0.485 0.356 0.274
design 0, 1.0, 1.7, 2.8, 4.7, 7.8, 13, 22, 36, 60 , T = 60
0.10 1 0 0.638 0.380 0.491 0.352 0.360 0.493 0.328 0.346 0.257
0.10 .5 0 0.613 0.380 0.440 0.352 0.478 0.488 0.328 0.613 0.640
0.04 .5 0 0.609 0.380 0.411 0.449 0.360 0.488 0.417 0.610 0.641
0.10 1 .9 0.614 0.380 0.491 0.417 0.319 0.493 0.529 0.551 0.265
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taken from Woutersen et al. (2001) and Piersma et al. (2002). We list their various ef-
ficiencies in Table 9 relative to our optimal designs constructed under the log-normality
assumption. Generally, the efficiencies of these designs are low for estimating CED or
for discriminating between competing models in the stipulated class. They range from
as low as 2% to mostly below 50%, and in a couple of instances about 67% for model
discrimination. We see that in nearly all cases the minimal efficiency of the maximin
compound design is greater than the efficiencies of the designs used by toxicologists.
Additional calculation not shown here also reveals that the efficiencies of maximin com-
pound designs are higher than the corresponding efficiencies of the used designs by at
least on 10%. This means that any confidence interval for CED constructed from the
maximin optimal design is at least on 10% shorter than those from the used designs. In
many cases the improvement is even more substantial. We also compare performance
of these used designs with optimal designs constructed under the normality assumption
and the over trend is quite similar.
4.3 Performance of maximin optimal design in practice
All our optimal designs were found under a large sample assumption. These optimal
designs minimize the asymptotic variance of the estimated CED obtained via the delta
method. For this reason it is important to investigate the superiority of the optimal
designs for sample size observed in practice. The purpose here is to briefly compare
variances of the estimated CED from the maximin CED-optimal design and a design
used by toxicologists in a real example with a relatively small sample size.
In Piersma et al. (2002), rats were prenatally exposed to diethylstilbestrol and the im-
plemented design ξu had 6 animals in each of the 10 dose groups at 0, 1.0, 1.7, 2.8, 4.7,
7.8, 13, 22, 36 and 60 mg/kg body weight per day. This means that we have 60 observa-
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tions on the design space [0, 60]. The maximin CED-optimal design ξmm for b = 0.1, d =
1, c = 0 has four dose levels and is given by {0, 5.2, 15.4, 60; 14/60, 21/60, 19/60, 6/60}.
We simulate data with a = 1 and σ = 0.05 and several values of parameters b, d and
c with 1000 replicates in each simulation. In Table 10 we report simulated normalized
variances of the estimated CED from the two designs under normality assumption. It is
reassuring that we observe that in all the cases considered here, the variance obtained
from the maximin optimal design ξmm is consistently smaller than the variance obtained
from the design ξu used in practice. This implies that use of our proposed designs can
save experimental cost for toxicologists and more importantly, in reducing the number
of animals required in the study. In addition, unlike designs used by toxicologists, our
designs are based on firm statistical considerations.
Table 10: Simulated normalized variance of CED for several true values of parameters.
b d c Var(ĈED) with ξmm Var(ĈED) with ξu
0.10 1.0 0.0 3.77 5.56
0.10 0.5 0.0 172.1 250.3
0.06 0.5 0.0 1821.0 3011.2
0.10 1.0 0.2 13.84 20.81
0.10 1.0 0.9 1850.4 3106.8
4.4 A design web site for practitioners
We conclude this paper with a reference to our web site where algorithms for gen-
erating optimal designs in this paper will be implemented very shortly. We believe
that to facilitate use of optimal design ideas in practice, design tools should be readily
available to practitioners. We thank the National Institute of General Medical Sci-
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ences for funding the construction and maintenance of the site. This site is housed at
http://www.optimal-design.org/ and visitors can generate a variety of optimal designs.
We expect that algorithms used to generate the optimal designs in this paper will be
available on this site shortly.
Presently, the site contains a list of models commonly used in the biological sciences,
along with information and references on optimal design issues. The visitor selects an
appropriate model, an optimality criterion and inputs parameters for the design prob-
lem. The generated design is displayed, and when appropriate, is also accompanied
by a plot of the directional derivative of the optimality criterion. Depending on the
features exhibited in this plot, we may or may not confirm the optimality of the gen-
erated design over all designs on the design space. This site also calculates efficiencies
of user-supplied designs so that practitioners can easily compare their designs with the
optimum and make an informed decision whether to stray away from the optimum and
if so by how much. For space considerations, we omit further discussion and refer the
reader to our web site. We hope that the site will promote use of optimal design ideas
in practice.
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